⌘K

Login Start Free

Home/Filings/4/0001209191-22-024916

4//SEC Filing

Subramanian Sanjay 4

Accession 0001209191-22-024916

CIK 0001693011other

View on SEC.gov Company Profile

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 4:05 PM ET

Size

4.6 KB

Accession

0001209191-22-024916

Insider Transaction Report

Form 4

Period: 2022-04-19

Inozyme Pharma, Inc.INZY

Subramanian Sanjay

SVP, CFO & Head of BD

Transactions

Purchase
Common Stock
2022-04-19$3.69/sh+27,100$99,999→ 27,100 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Inozyme Pharma, Inc.

CIK 0001693011

Entity typeother

Related Parties

1

filerCIK 0001790246

Filing Metadata

Form type: 4
Filed: Apr 19, 8:00 PM ET
Accepted: Apr 20, 4:05 PM ET
Size: 4.6 KB

View on SEC.gov